(Q37774761)

23 August 2017

Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed (English)

1 reference

23 August 2017

0 references

prevention of HIV/AIDS

0 references

author

Louisa Degenhardt

1

1 reference

23 August 2017

Tim Rhodes

4

0 references

Matthew Hickman

object named as

Matt Hickman

6

0 references

Peter Vickerman

object named as

Peter Vickerman

3

0 references

Carl Latkin

5

object named as

Carl Latkin

1 reference

23 August 2017

Bradley Mathers

2

1 reference

PubMed ID

20650522

23 August 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

23 August 2017

1 reference

23 August 2017

376

1 reference

23 August 2017

9737

1 reference

23 August 2017

285-301

1 reference

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Migration and transmission of blood-borne infections among injection drug users: understanding the epidemiologic bridge

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Per-contact risk of human immunodeficiency virus transmission between male sexual partners

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

HIV and risk environment for injecting drug users: the past, present, and future.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Risk environments and drug harms: A social science for harm reduction approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

HIV voluntary counseling and testing and behavioral risk reduction in developing countries: a meta-analysis, 1990--2005.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000-2004

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Effectiveness of interventions to prevent sexually transmitted infections and human immunodeficiency virus in heterosexual men: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Outcome, attrition, and family-couples treatment for drug abuse: a meta-analysis and review of the controlled, comparative studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Long-term effects of an HIV/STI sexual risk reduction intervention for heterosexual couples.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Effectiveness of peer education interventions for HIV prevention in developing countries: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Condom effectiveness in reducing heterosexual HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

HIV prevention cost-effectiveness: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Substitution treatment of injecting opioid users for prevention of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Sustained-Release Naltrexone For Opioid Dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Oral naltrexone maintenance treatment for opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Antidepressants for cocaine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Dopamine agonists for cocaine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Anticonvulsants for cocaine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Effectiveness of interventions for the prevention of HIV and other sexually transmitted infections in female sex workers in resource poor setting: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

The role of safer injection facilities in the response to HIV/AIDS among injection drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

The cost-effectiveness of Vancouver's supervised injection facility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Needles That Kill: Modeling Human Immunodeficiency Virus Transmission via Shared Drug Injection Equipment in Shooting Galleries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Heroin maintenance for chronic heroin dependents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Inpatient versus other settings for detoxification for opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Preventing and curtailing injecting drug use: a review of opportunities for developing and delivering 'route transition interventions'

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

People who use drugs, HIV, and human rights

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

1 reference

7 January 2021

HIV seroconversion among injection drug users in detention, Tehran, Iran

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Randomised, controlled, community-level HIV-prevention intervention for sexual-risk behaviour among homosexual men in US cities. Community HIV Prevention Research Collaborative

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Structural approaches to HIV prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Coming to terms with complexity: a call to action for HIV prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Opioid substitution and HIV/AIDS treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Structural interventions: concepts, challenges and opportunities for research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Transition and the HIV risk environment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

HIV in prison in low-income and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Interventions to reduce HIV transmission related to injecting drug use in prison

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

An informal school-based peer-led intervention for smoking prevention in adolescence (ASSIST): a cluster randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Patterns of HIV prevalence and HIV risk behaviors among injection drug users prior to and 24 months following implementation of cross-border HIV prevention interventions in northern Vietnam and southern China.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

The Risk Avoidance Partnership: Training Active Drug Users as Peer Health Advocates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Changing drug users' risk environments: peer health advocates as multi-level community change agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Outcomes of a peer HIV prevention program with injection drug and crack users: the Risk Avoidance Partnership

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Microfinance and HIV/AIDS prevention: assessing its promise and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Housing status and HIV risk behaviors: implications for prevention and policy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: a qualitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Syringe possession arrests are associated with receptive syringe sharing in two Mexico-US border cities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

The stepped wedge trial design: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960742-8

7 January 2021

10.1016/S0140-6736(10)60742-8

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20650522